| Autor: |
Hall AR; The Hatter Cardiovascular Institute, University College London, London, UK., Burke N; The Hatter Cardiovascular Institute, University College London, London, UK., Dongworth RK; The Hatter Cardiovascular Institute, University College London, London, UK., Kalkhoran SB; The Hatter Cardiovascular Institute, University College London, London, UK., Dyson A; Division of Medicine, University College London, London, UK., Vicencio JM; The Hatter Cardiovascular Institute, University College London, London, UK., Dorn GW 2nd; Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA., Yellon DM; The Hatter Cardiovascular Institute, University College London, London, UK., Hausenloy DJ; The Hatter Cardiovascular Institute, University College London, London, UK. d.hausenloy@ucl.ac.uk.; Cardiovascular and Metabolic Disorders Program, Duke-National University Singapore Graduate Medical School, Singapore, Singapore. d.hausenloy@ucl.ac.uk.; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore. d.hausenloy@ucl.ac.uk. |
Full text from SpringerLink